Delivery Order SPE2DB20D7066-SPE2DB25FC4CD
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $1,003.18 delivery order to AmerisourceBergen Drug Corp for medroxyprogesterone on September 13, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement executed under the company's existing contract vehicle. The work will be performed at the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,649.15 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a hormone-based pharmaceutical product. This non-competitive delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,839.57 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/ml. This competitive award, issued on September 4, 2025, carries a firm fixed price structure with performance completion targeted for September 5, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,495.01 to AmerisourceBergen Drug Corp for Medroxyprogesterone 150 mg/mL, a progestin medication used in hormone replacement therapy and contraceptive applications. The contract, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, carries a firm fixed price and represents a non-competitive delivery order. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Medroxyprogesterone 150 mg/ml, a synthetic progestin medication used for contraception and hormone therapy. This firm fixed-price delivery order, valued at $1,711.22, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026. The delivery is...
- The Defense Logistics Agency awarded a delivery order valued at $3,123.41 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a synthetic progestin used in hormone therapy and contraceptive applications. This firm fixed-price contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical. The contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Medroxyprogesterone 150 mg/mL. The contract has a ceiling value of $2,309.68 and was awarded on September 20, 2022, with a completion date of September 21, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at approximately $629 to Amerisourcebergen Drug Corporation for the supply of 150 mg/ml medroxyprogesterone. As the prime contractor, Amerisourcebergen will deliver the medication to a location in Conshohocken, Pennsylvania under a firm fixed price contract executed from August 17 to August 18, 2023. The parent company, Amerisourcebergen Corporation, will perform through its corporate office division. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $306 delivery order to Amerisourcebergen Drug Corporation for 150 mg/ml medroxyprogesterone. The order is placed against an existing indefinite-delivery/indefinite-quantity contract vehicle and will be performed in Conshohocken, Pennsylvania over a three-day period concluding on July 3, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No subcontractors or set-aside...
- The Defense Logistics Agency awarded a $2,749.79 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical to the agency from its facility in Conshohocken, Pennsylvania. Performance is required between August 31, 2023 and September 1, 2023 to support the Defense Logistics Agency's medical supply chain needs. No subcontractors or set aside...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4CDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Medroxyprogesterone 150 mg/ml, a hormone treatment medication. This firm fixed-price delivery order, valued at $2,343.72, represents a non-competitive set-aside contract and is scheduled for ultimate completion by July 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs and federal agencies worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling diverse medical supply requirements through competitively awarded orders with consistent firm fixed-price structures, supporting critical healthcare operations for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/17/25 |